VALERIE HERBER: Open Payments
NPI 1790186807 · PLATTEVILLE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 33 payments from 12 companies in 2025. Trend: 2023 $437 · 2024 $493 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $154 |
| Alkermes, Inc. | 5 | $103 |
| Lundbeck LLC | 4 | $103 |
| ABBVIE INC. | 4 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: INGREZZA, REXULTI, VRAYLAR, LYBALVI, ABILIFY ASIMTUFII, TRINTELLIX, SPRAVATO, COBENFY.
Industry payments across WI — which companies pay providers there.
